# PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel

> **NCT02855346** · PHASE1 · COMPLETED · sponsor: **International Partnership for Microbicides, Inc.** · enrollment: 24 (actual)

## Conditions studied

- HIV Prevention

## Interventions

- **COMBINATION_PRODUCT:** 200 mg of DPV + 320 mg LNG
- **COMBINATION_PRODUCT:** 200 mg of DPV

## Key facts

- **NCT ID:** NCT02855346
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-03
- **Primary completion:** 2017-08-18
- **Final completion:** 2017-08-18
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02855346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02855346, "PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02855346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*